NASDAQ:CLDX   Celldex Therapeutics, Inc.
Good time to enter CLDX!
(1) rising trendline
(2) Zacks Rank #2 = buy (short-term for next 1-3 months)
(3) Zacks ABR (5 brokers) = 1.80 (almost strong buy); past brokers' recommendations = 2 holds, 3 buys, 0 strong buy, 0 sell, 0 strong sell
(4) Zacks' Average Target Price = $6.63 (more than double current price of $3.03)
(5) Risk-Reward ratio = 1:1+

Let me know what you think! Peace
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。